Delving into Long-term Follow-Up of Subjects in a Phase 1/2a Clinical Trial of an Allogeneic, Bioengineered hESC-Derived RPE Implant for Advanced Dry Age-Related Macular Degeneration: Next Steps in Development
Time: 3:30 pm
day: Conference Day 1
Details:
- Design of CPCB-RPE1
- Results of Phase 1/2a Clinical Trial Through Long-term Follow-up
- Next Steps in the Development Path for the Product
